Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03840915
Title M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors EMD Serono Research & Development Institute, Inc.

lung non-small cell carcinoma


Cisplatin + M7824 + Pemetrexed Disodium

Docetaxel + M7824

Carboplatin + M7824 + Pemetrexed Disodium

Cisplatin + Gemcitabine + M7824

Carboplatin + Gemcitabine + M7824

Carboplatin + M7824 + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA | FRA | BEL

Additional content available in CKB BOOST